Complete suite of modern patient, prescriber,
and national data products for today's complex
therapies
Compass Prescriber includes HCP-level projections
for more than 4,000 brands and their prescriptions and
procedures
PLEASANTON,
Calif., Jan. 30, 2024 /PRNewswire/ -- Veeva
Systems (NYSE: VEEV) today announced the availability of the
full Veeva Compass Suite of commercial data products for a
more complete view into patient populations and HCP-level insight.
Veeva Compass Prescriber and Veeva Compass National are the first
to deliver projections for both retail prescriptions and complex
procedures, including in-office administered therapies, injections,
and infusions. Veeva Compass Suite also includes Compass Patient,
granular, longitudinal patient data spanning prescriptions,
procedures, and diagnoses. Veeva Compass products are licensed by
the brand and give brands unlimited data access, including
historical data.
"Veeva Compass Suite delivers the data the
industry needs for a faster, more precise approach to
commercialization," said Mike
Rifflard, vice president, operations, rare
disease, ANI Pharmaceuticals. "With Veeva Compass, we
accelerated our product launch by giving field teams a more
complete and timely view of our customers."
Veeva Compass data products are available for the
U.S. market today and include:
- Veeva Compass Patient provides granular, anonymous
patient data, including prescriptions, procedures, and diagnoses
for market assessment, patient journey analytics, patient finding,
HCP segmentation and targeting, and triggers and alerts.
- Veeva Compass Prescriber includes projected
prescriptions and procedures data at the HCP, HCO, and zip code
levels for HCP segmentation and targeting, field planning,
incentive compensation, and competitive intelligence.
- Veeva Compass National is projected prescriptions
and procedures data at the state and national levels for
forecasting, market share tracking, and commercial strategy.
"The availability of the full Veeva Compass Suite of data
products is a major milestone for the industry and for Veeva," said
Peter Stark, executive vice
president and general manager, Veeva Compass. "We are excited to
deliver significant innovations in commercial data for life
sciences. Powered by a simple, modern data architecture, Veeva
Compass handles both retail and complex therapies for more than
4,000 brands."
Additional Information For more on Veeva Compass,
visit: veeva.com/Compass
Connect with Veeva on LinkedIn:
linkedin.com/company/veeva-systems
About Veeva Systems
Veeva is the global leader in
cloud software for the life sciences industry. Committed to
innovation, product excellence, and customer success, Veeva serves
more than 1,000 customers, ranging from the world's largest
biopharmaceutical companies to emerging biotechs. As a Public
Benefit Corporation, Veeva is committed to balancing the interests
of all stakeholders, including customers, employees, shareholders,
and the industries it serves. For more information,
visit veeva.com.
Veeva Forward-looking Statements
This release contains
forward-looking statements regarding Veeva's products and services
and the expected results or benefits from use of our products and
services. These statements are based on our current expectations.
Actual results could differ materially from those provided in this
release and we have no obligation to update such statements. There
are numerous risks that have the potential to negatively impact our
results, including the risks and uncertainties disclosed in our
filing on Form 10-Q for the period ended October 31, 2023, which you can find here (a
summary of risks which may impact our business can be found on
pages 38 and 39), and in our subsequent SEC filings, which you can
access at sec.gov.
Contact:
Alison Borris
Veeva Systems
925-226-8821
alison.borris@veeva.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/now-available-veeva-compass-suite-of-commercial-data-products-302047529.html
SOURCE Veeva Systems